NUWE
Nuwellis·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 3
Stock Price Surged Significantly
Significant Inflow of Main Funds
Ample Liquidity
High Gross Profit Margin
Gap Up
Significant Net Income Decline
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About NUWE
Nuwellis, Inc.
A medical technology company that manufactures Aquadex SmartFlow system for ultrafiltration therapy to treat Hypervolemia
Healthcare Equipment and Supplies
08/22/2002
02/16/2012
NASDAQ Stock Exchange
38
12-31
Common stock
12988 Valley View Road, Eden Prairie, Minnesota 55344
--
Nuwellis, Inc., Sunshine Heart, Inc., was incorporated in Delaware on August 22, 2002. The company started operations in November 1999 through Sunshine Heart, Inc. Pte Ltd., and is currently a wholly-owned subsidiary in Australia. The company is a medical technology company dedicated to changing the lives of patients with fluid overload through science, collaboration and innovative technologies. The C-pulse system utilizes intra-aortic balloon counterpulsators for treatment based on scientific principles by reducing the workload of pumping blood to the body, while increasing the flow of canned arteries to the left ventricle.
Earnings Call
Q1/2025
Estimate EPS--
Actual EPS-0.69
Estimate Revenue2.50M
Actual Revenue1.90M
Nuwellis Q1 2025: Unraveling Contradictions in Outpatient Pipeline and REVERSE-HF Trial Timelines
May 20,2025 03:29
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS--
Actual EPS-60.98
Estimate Revenue2.20M
Actual Revenue1.73M
Nuwellis, Inc. Q2 2025: Unpacking Key Contradictions in Revenue, Clinical Trials, and Outpatient Expansion
Aug 14,2025 02:45
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
NUWE has released its 2025 Q3 earnings. EPS was reported at 0.56, versus the expected -17.22, beating expectations. The chart below visualizes how NUWE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
NUWE has released its 2025 Q3 earnings report, with revenue of 2.22M, reflecting a YoY change of -6.34%, and net profit of 468.00K, showing a YoY change of -80.15%. The Sankey diagram below clearly presents NUWE's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
